CD44 and breast cancer: Increased ESRP1 can enrich for CD44v; thus, consistent with the prognostic ability ofESRP1, higher levels of CD44v, but not high CD44s or total CD44 levels, areprognostic markers for distant metastases in lung and breast cancer.79